title: Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.
abstract: OBJECTIVE
  The diagnosis of Zollinger-Ellison syndrome requires secretin testing in 60% of patients. Even with secretin, the diagnosis may be difficult because variable responses occur, and 6-30% have negative testing. The basis for variability or negative responses is unclear. It is unknown whether the tumor density of secretin receptors or the presence of a secretin-receptor-variant, which can act as a dominant negative, is important. The aim of this study was to investigate these possibilities.
  
  
  METHODS
  Secretin-receptor and variant mRNA expression was determined in gastrinomas using real-time PCR from 54 Zollinger-Ellison syndrome patients. Results were correlated with Western blotting, secretin-receptor immunohistochemistry, with gastrin-provocative test results and tumoral/clinical/laboratory features.
  
  
  RESULTS
  Secretin-receptor mRNA was detectible in all gastrinomas but varied 132-fold with a mean of 0.89 +/- 0.12 molecules per beta-actin. Secretin-receptor PCR results correlated closely with Western blotting (r = 0.95; P < 0.0001) and receptor immunohistochemistry (P = 0.0015; r = 0.71). The variant was detected in all gastrinomas, but levels varied 102-fold and were 72-fold lower than the total. Secretin-receptor levels correlated with variant levels, Deltasecretin, but not Deltacalcium and with tumor location, but not growth, extent, or clinical responses. Variant levels did not correlate with the Deltasecretin. Detailed analysis provides no evidence that variant expression modified the secretin-receptor response or accounted for negative tests.
  
  
  CONCLUSIONS
  Secretin-receptor and secretin-receptor-variant expressions occur in all gastrinomas. Because the expression of the total, but not variant, correlated with the secretin results and no evidence for dominant negative activity of the variant was found, our results suggest that the total secretin-receptor density is an important determinant of the secretin test response.
authors: Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
authors: Scott H
authors: SH
authors: Long
authors: Marc J
authors: MJ
authors: Berna
authors: Michelle
authors: M
authors: Thill
authors: Andrea
authors: A
authors: Pace
authors: Tapas K
authors: TK
authors: Pradhan
authors: K Martin
authors: KM
authors: Hoffmann
authors: Jose
authors: J
authors: Serrano
authors: Robert T
authors: RT
authors: Jensen
mesh_terms: D015153:Blotting, Western; D002118:Calcium / Q000378:metabolism*; D018076:DNA, Complementary / Q000235:genetics; D005260:Female; D015408:Gastrinoma / Q000235:genetics*; D005786:Gene Expression Regulation / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D018761:Multiple Endocrine Neoplasia Type 1 / Q000235:genetics; D010190:Pancreatic Neoplasms / Q000235:genetics*; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D043562:Receptors, G-Protein-Coupled / Q000235:genetics* / Q000378:metabolism*; D011964:Receptors, Gastrointestinal Hormone / Q000235:genetics* / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015043:Zollinger-Ellison Syndrome / Q000235:genetics* / Q000378:metabolism*
chemical_list: D018076:DNA, Complementary; D012333:RNA, Messenger; D043562:Receptors, G-Protein-Coupled; D011964:Receptors, Gastrointestinal Hormone; C029937:secretin receptor; D002118:Calcium
references: Diagn Mol Pathol. 2000 Mar;9(1):47-57
references: 10718213
references: Dig Dis Sci. 1987 Mar;32(3):232-8
references: 3816477
references: Am J Physiol. 1988 Nov;255(5 Pt 1):G596-602
references: 2847543
references: Arch Histol Cytol. 1989;52 Suppl:233-40
references: 2510785
references: Int J Pancreatol. 1989 Sep;5(2):191-201
references: 2600453
references: Gastroenterology. 1990 Apr;98(4):936-54
references: 2179034
references: Am J Gastroenterol. 1991 Feb;86(2):129-34
references: 1992623
references: Surgery. 1992 Dec;112(6):1002-8; discussion 1008-9
references: 1455303
references: Ann Intern Med. 1993 Aug 1;119(3):199-206
references: 8323088
references: Ann Surg. 1993 Aug;218(2):138-44
references: 8342993
references: J Cell Physiol. 1994 Dec;161(3):519-25
references: 7962132
references: Am J Med. 1994 Nov;97(5):436-44
references: 7977432
references: Gastroenterology. 1997 Feb;112(2):335-47
references: 9024287
references: J Clin Oncol. 1997 Jun;15(6):2420-31
references: 9196158
references: Mol Endocrinol. 1997 Aug;11(9):1305-18
references: 9259321
references: Arch Surg. 1998 Jan;133(1):13-6; discussion 17
references: 9438752
references: J Clin Oncol. 1999 Feb;17(2):615-30
references: 10080607
references: Trends Pharmacol Sci. 1999 Jul;20(7):294-301
references: 10390648
references: FEBS Lett. 1999 Jul 23;455(3):209-14
references: 10437774
references: J Biol Chem. 2004 Nov 5;279(45):47017-23
references: 15355989
references: Clin Cancer Res. 2005 May 1;11(9):3233-42
references: 15867218
references: Mol Endocrinol. 2005 Aug;19(8):2132-44
references: 15860547
references: Am J Pathol. 2005 Oct;167(4):959-68
references: 16192632
references: Biochem Biophys Res Commun. 2006 Sep 1;347(3):698-706
references: 16842753
references: Medicine (Baltimore). 2006 Nov;85(6):331-64
references: 17108779
references: J Surg Res. 1985 Oct;39(4):331-7
references: 3930881
references: Tohoku J Exp Med. 1986 Apr;148(4):459-60
references: 3738909
references: Trends Pharmacol Sci. 2000 Aug;21(8):304-8
references: 10918636
references: EMBO J. 2000 Aug 15;19(16):4265-71
references: 10944109
references: Neuropharmacology. 2000 Sep;39(12):2267-77
references: 10974310
references: J Clin Endocrinol Metab. 2000 Oct;85(10):3866-73
references: 11061551
references: Medicine (Baltimore). 2000 Nov;79(6):379-411
references: 11144036
references: Medicine (Baltimore). 2001 May;80(3):189-222
references: 11388095
references: Mol Endocrinol. 2001 Sep;15(9):1529-38
references: 11518802
references: Gastroenterology. 2002 Feb;122(2):500-11
references: 11832464
references: Cancer Res. 2002 Sep 15;62(18):5223-9
references: 12234988
references: Ann Surg. 2003 May;237(5):650-7; discussion 657-9
references: 12724631
references: Medicine (Baltimore). 2004 Jan;83(1):43-83
references: 14747767
references: Ann Surg. 2004 May;239(5):617-25; discussion 626
references: 15082965
references: Gastroenterology. 1972 Apr;62(4):626-31
references: 5020875
references: Gut. 1977 Feb;18(2):128-35
references: 323117
references: Ann Intern Med. 1977 Dec;87(6):680-6
references: 931203
references: Gastroenterology. 1980 Dec;79(6):1324-31
references: 7439637
references: Dig Dis Sci. 1982 Dec;27(12):1130-6
references: 7172964
references: Hokkaido Igaku Zasshi. 1985 Mar;60(2):206-16
references: 2987090